Oral Ulcer Clinical Trial
Official title:
Muco-bioadhesive Gel Containing Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis: A Randomized Clinical Study
A randomized double-blind placebo controlled trial will be carried out on 20 patients complaining from aphthus ulcer and 10 patient healthy control 10 patients treated with mucoadhesive gel containing 2% of basil extract 4 times per day (test group) for 20 min after every meal and before going to bed. The other 10 patients treated by mucoadhesive gel without drug which was used as placebo (composed from 6% w/w PVA (Mw = 31-50 kDa, 98-99% hydrolysed) and 2% w/w sodium tetraydroxy borate) 4 times per day 10 healthy patients will be selected to participate in the study to test the salivary level of endocan in the healthy individuals (negative control group)
A randomized double-blind placebo controlled trial will be carried out on 20 patients complaining from aphthus ulcer and 10 patient healthy control. Inclusion criteria will be: (i) age > 18 years; (ii) a clear history of RAS(recurrent apthous stomatitis)occurring no less than four times a year; (iii) presentation with one or two ulcers measuring 10 mm in diameter for 48 hours and yet to receive treatment; (iv) ulcers that took > 5 days to resolve without treatment. Individuals will excluded if they: (i) had underlying systemic disease(s) or a history of immunologic disorder(s); (ii) were taking immunomodulatory agents or systemic nonsteroidal anti-inflammatory drugs < 1 month before study commencement; (iii) are smokers; (iv) are pregnant; (v) had a history of abusing drugs or alcohol; (vi) could not provide written informed consent. 10 patients treated with mucoadhesive gel containing 2% of basil extract 4 times per day (test group) for 20 min after every meal and before going to bed. The other 10 patients treated by mucoadhesive gel without drug which was used as placebo (composed from 6% w/w PVA (Mw = 31-50 kDa, 98-99% hydrolysed) and 2% w/w sodium tetraydroxy borate) 4 times per day 10 healthy patients will be selected to participate in the study to test the salivary level of endocan in the healthy individuals (negative control group) ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03239834 -
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
|
||
| Not yet recruiting |
NCT04989049 -
Therapeutic Effect of Folic Acid in Healing of Oral Ulcers
|
Early Phase 1 | |
| Completed |
NCT06379438 -
Treatment of Aphtous Ulcers With Photodynamic Therapy
|
N/A | |
| Withdrawn |
NCT02769494 -
The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer
|
Phase 3 | |
| Completed |
NCT05413096 -
Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis
|
Early Phase 1 | |
| Completed |
NCT03633292 -
Aloe Vera and Chlorhexidine Against Traumatic Oral Ulcers
|
Phase 4 | |
| Completed |
NCT00333749 -
The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases
|
Phase 1 | |
| Completed |
NCT05147376 -
Effectiveness of a Curcumin Mouthwash in Preventing Traumatic Ulcers in Patients With Fixed Orthodontic Appliances
|
Early Phase 1 | |
| Completed |
NCT04383236 -
Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis
|
N/A | |
| Completed |
NCT03167632 -
Oral Ulcer Prevalence: Hospital-based Cross-sectional Study
|
N/A | |
| Enrolling by invitation |
NCT05288478 -
Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa.
|
Phase 2 | |
| Recruiting |
NCT05449548 -
Lenalidomide in the Treatment of Mucosal Behçet's Syndrome
|
N/A | |
| Completed |
NCT05032248 -
Uses of Tacrolimus in Behcet Disease
|
N/A |